Margareth C Ozelo Selected Research

Matrix Metalloproteinase 1 (Interstitial Collagenase)

1/2020

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Margareth C Ozelo Research Topics

Disease

23	Hemophilia A (Haemophilia) 04/2024 - 03/2006
17	Hemorrhage 04/2024 - 10/2012
10	Hemophilia B (Haemophilia B) 08/2023 - 03/2006
3	Body Weight (Weight, Body) 01/2023 - 12/2013
3	Thrombosis (Thrombus) 01/2022 - 10/2012
3	von Willebrand Diseases (von Willebrand's Disease) 01/2022 - 10/2012
2	Joint Diseases (Joint Disease) 01/2022 - 10/2012
1	Pain (Aches) 03/2024
1	Nausea 01/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Headache (Headaches) 01/2022
1	Thrombotic Thrombocytopenic Purpura 01/2022
1	Menorrhagia 12/2021
1	Hemarthrosis 02/2021
1	Stroke (Strokes) 01/2020
1	Thrombasthenia (Glanzmann Thrombasthenia) 06/2017
1	Angiodysplasia 06/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2012
1	Venous Thromboembolism 10/2012
1	Multiple Myeloma 03/2008
1	Down Syndrome (Down's Syndrome) 07/2006
1	Ischemia 07/2006
1	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 07/2006
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 07/2006
1	Atherosclerotic Plaque (Atheroma) 10/2004
1	Myocardial Infarction 08/2004
1	Coronary Disease (Coronary Heart Disease) 08/2004

Drug/Important Bio-Agent (IBA)

15	Factor VIII (Coagulation Factor VIII)IBA 04/2024 - 07/2009
7	Factor IX (Coagulation Factor IX)FDA LinkGeneric 08/2023 - 03/2006
6	factor IX Fc fusion proteinIBA 08/2023 - 12/2013
4	Valoctocogene RoxaparvovecIBA 04/2024 - 01/2022
4	AntibodiesIBA 11/2023 - 12/2010
3	AnticoagulantsIBA 12/2021 - 07/2006
2	emicizumabIBA 11/2023 - 03/2022
2	von Willebrand factor drug combination factor VIIIIBA 10/2019 - 10/2019
2	Platelet Membrane GlycoproteinsIBA 10/2004 - 08/2004
1	Chromogenic CompoundsIBA 04/2024
1	human F8 protein FDA Link 01/2024
1	Monoclonal AntibodiesIBA 11/2023
1	B-domain-deleted factor VIIIIBA 01/2023
1	IsoantibodiesIBA 07/2022
1	Blood Coagulation Factors (Coagulation Factor)IBA 03/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	factor VIII-Fc fusion proteinIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	thiamine triphosphorate (TTP)IBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2021
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 12/2021
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2020
1	Thalidomide (Thalomid)FDA Link 06/2017
1	recombinant factor VIII N8IBA 12/2015
1	Peptide Elongation Factor 1 (EF-1)IBA 06/2014
1	Antigen-Antibody Complex (Immune Complex)IBA 06/2014
1	AntigensIBA 06/2014
1	Immunoglobulins (Immunoglobulin)IBA 06/2014
1	Neutralizing AntibodiesIBA 12/2010
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2008
1	Methionine (L-Methionine)FDA Link 03/2008
1	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 03/2008
1	methionine synthase reductaseIBA 03/2008
1	Thymidylate SynthaseIBA 03/2008
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 03/2008
1	Enoxaparin (Lovenox)FDA LinkGeneric 07/2006
1	Warfarin (Coumadin)FDA LinkGeneric 07/2006
1	Transcription Factors (Transcription Factor)IBA 07/2006
1	HirudinsIBA 07/2006
1	Thrombin FDA Link 07/2006
1	Human Platelet AntigensIBA 08/2004

Therapy/Procedure

7	Therapeutics 03/2024 - 10/2012
2	Operative Surgical Procedures 08/2023 - 10/2012
1	Pain Management 03/2024
1	Anesthesia 12/2021
1	Minor Surgical Procedures (Minor Surgery) 12/2021
1	Hydrotherapy (Whirlpool Bath) 03/2021
1	Aftercare (After-Treatment) 02/2021
1	Injections 12/2013
1	Perioperative Period 12/2013
1	Compression Stockings 10/2012
1	Early Ambulation 10/2012
1	Orthopedic Procedures 10/2012